Ireland - English - HPRA (Health Products Regulatory Authority)

chanelle medical unlimited company - fexofenadine hydrochloride - film-coated tablet - 120 milligram(s) - other antihistamines for systemic use; fexofenadine

Ireland - English - HPRA (Health Products Regulatory Authority)

azure pharmaceuticals ltd - fexofenadine hydrochloride - film-coated tablet - 120 milligram(s) - fexofenadine

New Zealand - English - Medsafe (Medicines Safety Authority)

viatris limited - fexofenadine hydrochloride 120mg - film coated tablet - 120 mg - active: fexofenadine hydrochloride 120mg excipient: croscarmellose sodium magnesium stearate maize starch microcrystalline cellulose opadry pink 03c54667 povidone purified water - relief of symptoms associated with seasonal allergic rhinitis in adults and children aged 12 years or older.

United States - English - NLM (National Library of Medicine)

major pharmaceuticals - fexofenadine hydrochloride (unii: 2s068b75zu) (fexofenadine - unii:e6582loh6v) - fexofenadine hydrochloride 30 mg - fexofenadine hydrochloride tablets are indicated for the relief of symptoms associated with seasonal allergic rhinitis in adults and children 6 years of age and older. fexofenadine hydrochloride tablets are indicated for treatment of uncomplicated skin manifestations of chronic idiopathic urticaria in adults and children 6 of age and older . fexofenadine hydrochloride tablets are contraindicated in patients with known hypersensitivity to fexofenadine and any of the ingredients of fexofenadine hydrochloride. rare cases of hypersensitivity reactions with manifestations such as angioedema, chest tightness, dyspnea, flushing and systemic anaphylaxis have been reported. teratogenic effects: pregnancy category c. there was no evidence of teratogenicity in rats or rabbits at oral doses of terfenadine up to 300 mg/kg (which led to fexofenadine exposures that were approximately 4 and 30 times, respectively, the exposure at the maximum recommended human daily oral dose of 180 mg of fexofenadine hydrochloride based on c

United States - English - NLM (National Library of Medicine)

rebel distributors corp - fexofenadine hydrochloride (unii: 2s068b75zu) (fexofenadine - unii:e6582loh6v), pseudoephedrine hydrochloride (unii: 6v9v2ryj8n) (pseudoephedrine - unii:7cuc9ddi9f) - fexofenadine hydrochloride 60 mg - fexofenadine hydrochloride and pseudoephedrine hydrochloride extended-release tablets are indicated for the relief of symptoms associated with seasonal allergic rhinitis in adults and children 12 years of age and older. symptoms treated effectively include sneezing, rhinorrhea, itchy nose/palate/ and/or throat, itchy/watery/red eyes, and nasal congestion. fexofenadine hydrochloride and pseudoephedrine hydrochloride extended-release tablets should be administered when both the antihistaminic properties of fexofenadine hydrochloride and the nasal decongestant properties of pseudoephedrine hydrochloride are desired (see clinical pharmacology). fexofenadine hydrochloride and pseudoephedrine hydrochloride extended-release tablets are contraindicated in patients with known hypersensitivity to any of its ingredients. due to its pseudoephedrine component, fexofenadine hydrochloride and pseudoephedrine hydrochloride extended-release tablets are contraindicated in patients with narrow-angle glaucoma or urinary retentio

New Zealand - English - Medsafe (Medicines Safety Authority)

douglas pharmaceuticals limited - fexofenadine hydrochloride 120mg; fexofenadine hydrochloride 120mg - film coated tablet - 120 mg - active: fexofenadine hydrochloride 120mg excipient: croscarmellose sodium hyprolose hypromellose iron oxide red iron oxide yellow macrogol 400 magnesium stearate microcrystalline cellulose opacode black s-1-8152hv povidone purified talc purified water titanium dioxide active: fexofenadine hydrochloride 120mg excipient: croscarmellose sodium hyprolose hypromellose iron oxide red iron oxide yellow macrogol 400 magnesium stearate microcrystalline cellulose opacode black s-1-27794 povidone purified talc purified water titanium dioxide

New Zealand - English - Medsafe (Medicines Safety Authority)

viatris limited - fexofenadine hydrochloride 120mg - film coated tablet - 120 mg - active: fexofenadine hydrochloride 120mg excipient: colloidal silicon dioxide croscarmellose sodium isopropyl alcohol magnesium stearate maize starch mannitol opadry pink 03b54504 powdered cellulose purified water - relief of symptoms associated with seasonal allergic rhinitis in adults and children aged 12 years or older. label claim: for the relief of symptoms of hay fever allergies: itchy and runny nose, itchy and watery eyes, sneezing, itchy throat.

Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

opella healthcare belgium sa-nv - fexofenadine hydrochloride 120 mg - eq. fexofenadine 112 mg - tablet - 120 mg - fexofenadine hydrochloride 120 mg - fexofenadine

United States - English - NLM (National Library of Medicine)

ncs healthcare of ky, inc dba vangard labs - fexofenadine hydrochloride (unii: 2s068b75zu) (fexofenadine - unii:e6582loh6v) - fexofenadine hydrochloride 60 mg - fexofenadine hydrochloride tablets are indicated for the relief of symptoms associated with seasonal allergic rhinitis in adults and children 2 years of age and older. fexofenadine hydrochloride tablets are indicated for treatment of uncomplicated skin manifestations of chronic idiopathic urticaria in adults and children 6 months of age and older. fexofenadine hydrochloride tablets are contraindicated in patients with known hypersensitivity to fexofenadine and any of the ingredients of fexofenadine hydrochloride tablets. rare cases of hypersensitivity reactions with manifestations such as angioedema, chest tightness, dyspnea, flushing and systemic anaphylaxis have been reported. pregnancy category c. there was no evidence of teratogenicity in rats or rabbits at oral doses of terfenadine up to 300 mg/kg (which led to fexofenadine exposures that were approximately 4 and 30 times, respectively, the exposure at the maximum recommended human daily oral dose of 180 mg of fexofenadine hydrochloride based on comparis

United States - English - NLM (National Library of Medicine)

physicians total care, inc. - fexofenadine hydrochloride (unii: 2s068b75zu) (fexofenadine - unii:e6582loh6v) - fexofenadine hydrochloride 30 mg - fexofenadine hydrochloride tablets are indicated for the relief of symptoms associated with seasonal allergic rhinitis in adults and children 6 years of age and older. symptoms treated effectively were sneezing, rhinorrhea, itchy nose/palate/throat, itchy/watery/red eyes. fexofenadine hydrochloride tablets are indicated for treatment of uncomplicated skin manifestations of chronic idiopathic urticaria in adults and children 6 years of age and older. it significantly reduces pruritus and the number of wheals. fexofenadine hydrochloride tablets are contraindicated in patients with known hypersensitivity to any of its ingredients.